-
Canceled24/06/2025
-
Today13/07/2025
Utilities
- indicates text translated automatically in your browsing language
Supply of the medicinal product Vyvgart 1000 mg/5.6 mL and 20 mg/mL (active substance efgartigimod alfa) Text automatically translated in your browsing language Automatically translated
Supply of the medicinal product Vyvgart 1000 mg/5.6 ml solution for injection (active ingredient efgartigimod alfa) and Vyvgart 20 mg/mlconcentrate for solution for infusion (active ingredient efgartigimod alfa), of indeterminate amount (additional provision 33 of Law 9/2017, on public sector contracts), by negotiated procedure without advertising, without competition of offers and ordinary processing, to the Pharmacy Service of the Nuestra Señora de Candelaria University Hospital. Text automatically translated in your browsing language Automatically translated
Type: price
Description: Precio.
Weight (percentage, exact): 100
This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.